Skip to content
Dr. John Bell
Ottawa-born Turnstone Biologics goes public on Nasdaq, expects to raise US$80M
Turnstone Biologics, an Ottawa-born biotech startup that landed more than $170 million in venture capital, is going public on the Nasdaq exchange.
Ottawa Changemakers: Ottawa scientist spearheads groundbreaking cancer treatments
Internationally-recognized scientist Dr. Jean-Simon Diallo is infecting cancer cells with viruses with his team at Virica Biotech in groundbreaking cancer treatment.
It’s a $1M win for Cancer Champions Breakfast in support of Ottawa Regional Cancer Foundation
Annual event raises most amount of money to date despite switching to a virtual format due to COVID-19 pandemic
Merkley and cycling team celebrated for support of cancer-fighting research at The Ottawa Hospital
If you’ve ever met Ottawa businessman Robert Merkley, president of Merkley Supply, there’s a good chance he’s tried to recruit you to join his team
Video: Who are Ottawa’s healthcare innovators?
Facebook Embedded Video Player As part of our print feature on Ottawa’s healthcare innovators, Techopia Live gathered a few of the researchers and entrepreneurs in
Ottawa biotech startup Turnstone Biologics raises $41.4M
An Ottawa biotech startup has received a US$41-million injection of venture capital to further develop its groundbreaking treatments that use the body’s own immune system
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
